STANDARD BIOTOOLS INC. — Director's Dealing 2022

Apr 7, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STANDARD BIOTOOLS INC. (LAB)
CIK: 0001162194
Period of Report: 2022-04-04

Reporting Person: Madaus Martin D (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-04-04	Common Stock	A	15852	—	Acquired	15852	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-04-04	Stock Option (Right to Buy)	$3.99	A	23401	Acquired	2032-04-04	Common Stock (23401.0)	Direct

Footnotes

F1: Represents Restricted Stock Units that vest in four equal annual installments beginning April 4, 2023.

F2: The Option becomes exercisable in four equal annual installments beginning on April 4, 2023.